ArticleAnnals of Saudi medicine

The risk of tuberculosis infection in 410 Saudipatients receiving adalimumab therapy.

Abdullah Al-Sohaim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.